Abivax Sa (ABVX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABVX Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Abivax Sa.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents578.69
Cash & Short-term Investments578.00
Other Current Assets38.71
Total Current Assets617.39
Goodwill net20.63
Other Assets, Noncurrent16.44
Total Assets654.46
Liabilities
Other Liabilities, Current70.58
Total Current Liabilities70.58
Total Long-term Debt0.00
Total Liabilities144.63
Stockholders' Equity
Other Equity509.83
Common Stockholder's Equity509.83
Total Stockholder's Equity509.83
Liabilities & Stockholder's Equity654.46
4 historic quarters locked

Sign in to unlock the full Abivax Sa balance sheet history.

About Abivax S A Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001956827-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.